Applied Genetic Technologies (AGTC)

Applied Genetic Technologies (AGTC) Stock Price & Analysis


AGTC Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.39
Average Volume (3M)N/A
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding67,632,195
10 Day Avg. Volume1,246,396
30 Day Avg. Volume1,966,600
Standard Deviation0.24
Financial Highlights & Ratios
Price to Book (P/B)1.51
Price to Sales (P/S)81.91
Price to Cash Flow (P/CF)1.80
P/FCF Ratio-0.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside-10.00% Downside
Rating ConsensusHold
Number of Analyst Covering6



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Applied Genetic Technologies’s price range in the past 12 months?
Currently, no data Available
What is Applied Genetic Technologies’s market cap?
Currently, no data Available
When is Applied Genetic Technologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Applied Genetic Technologies’s earnings last quarter?
Currently, no data Available
Is Applied Genetic Technologies overvalued?
According to Wall Street analysts Applied Genetic Technologies’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does Applied Genetic Technologies pay dividends?
    Applied Genetic Technologies does not currently pay dividends.
    What is Applied Genetic Technologies’s EPS estimate?
    Applied Genetic Technologies’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Applied Genetic Technologies have?
    Currently, no data Available
    What happened to Applied Genetic Technologies’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Applied Genetic Technologies?
    Currently, no hedge funds are holding shares in AGTC


    Applied Genetic Technologies Stock Smart Score

    This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
    Learn more about TipRanks Smart Score

    Company Description

    Applied Genetic Technologies

    Applied Genetic Technologies Corp. engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.


    Forecast EPS vs Actual EPS

    Currently, no data available
    Please return soon. This page is being updated.

    Similar Stocks
    Price & Change
    Gelesis Holdings
    Achieve Life Sciences
    Quince Therapeutics

    Popular Stocks

    What's Included in PREMIUM?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis